Circulating tumour cell (CTC) enumeration and overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with xaluritamig Meeting Abstract


Authors: Armstrong, A. J.; Appleman, L. J.; Danila, D. C.; Lin, C. C.; Lee, J. L.; Matsubara, N.; Ward, P. J.; Pook, D. W.; Kim, M.; Dorff, T. B.; Fischer, S. C.; Lin, Y. C.; Horvath, L. G.; Sumey, C.; Yang, Z.; Decato, B. E.; Englert, J. M.; Smith, K. M.; Lolkema, M.; Kelly, W. K.
Abstract Title: Circulating tumour cell (CTC) enumeration and overall survival (OS) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with xaluritamig
Meeting Title: ESMO Congress 2024
Journal Title: Annals of Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2024 Sep 13-17
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-09-01
Start Page: S971
End Page: S972
Language: English
ACCESSION: WOS:001326612902232
DOI: 10.1016/j.annonc.2024.08.1691
PROVIDER: wos
Notes: Meeting Abstract: 1610P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Daniel C Danila
    155 Danila